KNOWLEDGE, ATTITUDE, AND PERCEPTIONS OF PEOPLE TOWARDS COVID-19 VACCINATION IN ODA, ILEKUN, AND ESURE COMMUNITY IN AKURE SOUTH LOCAL GOVERNMENT AREA, ONDO

  • 0 Review(s)

Product Category: Projects

Product Code: 00008864

No of Pages: 57

No of Chapters: 5

File Format: Microsoft Word

Price :

₦3000

  • $

ABSTRACT

The research project studied the knowledge, attitude and perceptions of people towards COVID-19 vaccination in Oda, Ilekun and Esure communities in Akure south local government area, Ondo state. The corona virus disease 2019 (COVID 19) is a highly contagious infection which mainly affect the respiratory system of patients and has continued to threaten human existence globally, which has led to the development of vaccines in order to control the rate of infection and death associated with the disease. Questionnaires and the oral interview were structured to reveal the knowledge, attitude and perception of COVID-19 w=vaccination within Oda, Ilekun and Esure communities. Descriptive analysis was used for the research. The analysis was based on 115 questionnaires retrieved out of 120 questionnaires distributed and 17 oral interviews conducted. The findings and discussion of this study revealed that though the people have prior knowledge about the vaccination of COVID-19, the knowledge gotten was not enough and also, misinformation, fear of side effects and sociocultural factors influence their knowledge and perceptions from accepting COVID-19 vaccination. At the end of the research, recommendations were made to the government, to provide effective strategies to fight against fake news related to COVID-19, to the health workers, public awareness should be increased through health education. And to the communities, they should help in the dissemination of correct information about COVID-19 vaccination among themselves.

 

 

 

 

TABLE OF CONTENTS

TITLE PAGE                                                                                                                                   Title                                                                                                                         i

Certification                                                                                                            ii

Dedication                                                                                                              iii

Acknowledgement                                                                                                 iv

Abstract                                                                                                                  v

Tables of contents                                                                                                  vi

List of figure                                                                                                         vii

CHAPTER ONE

1.0    Introduction                                                                                                 1

1.1     Background of the Study                                                                            3

1.2    Aim of the Study                                                                                          4

1.3    Objectives of the Study                                                                                4-5

1.4    Statement of the Problem                                                                             5

1.5    Significance of the Study                                                                                     5    1.6    Assumptions                                                                                               5-6

1.7    Definition of Terms                                                                                        6

CHAPTER TWO

2.0   Literature Review                                                                                       7-10

2.1    Incidence                                                                                                  10-11

2.2   Mode of Transmission                                                                               11-12

2.3   Incubation Period of COVID-19                                                                  12

2.4   Reservoir of Infection                                                                                   13

2.5   Risk Factor for COVID-19 Transmission.                                                    13

2.6   Life Cycle                                                                                                  13-16

2.7   Signs and Symptoms of COVID-19                                                            16

2.8   Diagnosis of COVID-19                                                                            17-18

2.9   Prevention and Control of COVID-19                                                         18

2.10   Complications of COVID-19                                                                  18-20

2.11    Treatment of COVID-19                                                                       20-21

CHAPTER THREE

3.0    Research Methodology                                                                             22

3.1     Study Design                                                                                            22

3.2    Description of the Study Area                                                                 22-23

3.3   Sampling Size Determination                                                                    23

3.4    Sampling Techniques                                                                                23

3.5    Method of Data Collection.                                                                      23

3.6   Ethical Consideration                                                                                 23

CHAPTER FOUR

4.0   Data Presentation and Analysis                                                                  24

CHAPTER FIVE

 5.0  Summary                                                                                                     36

5.1  Discussion of Findings                                                                            36-39

5.2  Conclusion                                                                                                    39

5.3  Recommendations.                                                                                       40

5.4   Limitations of the Study                                                                              41

Reference

Questionnaire







 

LIST OF TABLES


Table 4.1: The age of the respondents                                                            24

Table 4.2: The sex of the respondents                                                            25

Table 4.3: The religion of the respondents                                                     25

Table 4.4: Respondent's occupation                                                                26

Table 4.5: Marital status of the respondents                                                    26

Table 4.6: Educational background of the respondents                                   27

Table 4.7: The ethnicity of the respondents                                                     27

Table 4.8: Have you heard about COVID-19 vaccine?                                    28    

Table 4.9: Have you been Vaccinated with COVID-19 vaccine?                    28

Table 4.10: If yes, after vaccination did you have any allergic reaction?         29

Table 4.11: Common reactions of COVID-19?                                                 29  

Table 4.12:  Have you encourage other people to go for their vaccination?     30

Table 4.13: If No, why?                                                                                    30

Table 4.14: How many times have you been vaccinated?                                 31

Table 4.15: If once, why?                                                                                  31

Table 4.16: COVID-19 is said to spread respiratory via respiratory droplet of an infected person                                                                                                   32

Table 4.17: Main clinical symptoms of COVID-19 are fever, cough, shortness of breath and fatigue                                                                                                        32

Table 4.18: COVID-19 symptom appears within 2-14 days                               33

Table 4.19: Are you aware of the safety precautions of COVID-19, such as wearing of medical or face mask, hand washing etc?                                         33

Table 4.20: Patients with underlying chronic diseases are more severe to cases and death                                                                                                                     34

Table 4.21: Isolation and treatment of people who are infected with COVID-19 Virus are effective ways to reduce the spread of the virus                                   34

Table 4.22: There is currently no effective care for COVID-19, but early detective and supportive treatment can help most patient recover from infection?            35         

 

                                                  




                


CHAPTER ONE


1.0. INTRODUCTION

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2 OR SARS CORONAVIRUS 2) that was first identified in December 2019 in Wuhan, Hubei, China. The incidence of COVID-19 has grown drastically in China and the virus has rapidly spread to more than 200 countries of the World since the late February 2020. On 28 February, 2020, World Health Organization (WHO) raised the global COVID-19 risk to highest level. COVID-19 outbreak has become a potential threat to the global public health. (Minhua, 2020).

COVID-19 primarily affects the respiratory system with range of symptom from mild rhinorrhea to severe respiratory distress syndrome. COVID-19 spread mainly between people who are in close contact (less than two metres or six feet) through small droplets produced during coughing sneezing or talking. Infected people exhale the contaminated droplets which are then inhale into the lungs or settle on other non-infected people's faces (mucosae) to cause new infection. People who show mild or non-specific symptoms are most infectious and may be infected up to 3days before symptoms appear i.e pre-symptomatic transmission. People remain infectious up to 6 to 12days in moderate cases and an average of 13 to 14days in severe cases. On 1 February 2020, the World Health Organization (WHO) indicated that transmission from asymptomatic cases is likely not a major driver of transmission. However, an epidemiological model of the beginning of the outbreak in China suggested that pre-symptomatic shedding may be typical among documented infections and that subclinical infections may have been the source of a majority of infections. And, there is some evidence of human-to-animal transmission of SARS-COV-2. Indirect contact is also another possible way of infection, it can occur via contaminated surface. Transmission may also occur through fomites in the immediate environment around the infected person. (Yadav, et al, 2020)

The symptoms of COVID-19 illness range from very mild (Fever and respiratory symptoms such as cough and shortness of breath) to severe (Pneumonia, severe acute respiratory syndrome and kidney failure) with a mortality rate around 40%. This virus is generally more fatal for Elderly person and those suffering from comorbidities like heart disease, lung disease, and diabetes, they are at higher risk of developing severe COVID-19 illness. On March 18, 2020 the CDC COVID-19 Response Team reported that 80% of COVID-19 related deaths were among the elderly aged >65 years. As a response to this serious global public threat, the World Health Organization (WHO) characterized the COVID-19 outbreak as a pandemic on March 11, 2020, since the number of COVID-19 cases outside China had increased by 13 fold and the number of affected countries had increased by 3 fold. (Olaimat, et al, 2020).

Vaccine are the most important public health measure and most effective strategy to protect the population from COVID-19 since SARS-COV-2 is highly contagious virus and affect populations globally. The competition from COVID-19 vaccine invention and development against the spread and catastrophic effects of the disease is ongoing and new, more effective vaccine are likely to be developed as we move through the pandemic with the distribution of Vaccines under ways, it is very important to examine commonly acceptance of COVID-19 vaccine. (Islam, et al, 2021).

For all countries, the final aim is the same: stop transmission and prevent the spread of the virus in order to save life. (WHO announces COVID-19 outbreak a pandemic).


1.1.    BACKGROUND OF THE STUDY

Ascertaining vaccine acceptance and hesitation among the general population and health workers is crucial to draw policy plans and access available resources to meet COVID-19 and overall health challenge to lessen the acute pandemic burden. (Elhadi, et al, 2021).

Infectious diseases are a permanent and inseparable companion of mankind. The most effective method of preventing many of them is vaccination. Thanks to Worldwide vaccination, smallpox has been eradicated, poliomyelitis is nearly eliminated, and the incidence of many other infectious diseases has been significantly Reduce. Currently, the incidence of many infectious diseases is low, especially in developed countries, where national immunization programs have existed for many years and children are routinely vaccinated; thus, there is little fear of these diseases. However, the number of parents who refuse to vaccinate their children has recently Increased. In Poland, there were approximately 2500 cases of vaccination refusal in 2009, and almost 40,000 in 2018. There are many reasons for vaccine refusal, including psychology reasons (i.e., Fear), philosophical beliefs (i.e., veganism), or religions background. Parents declare that their fear of vaccination is caused by the lack of information on vaccine components and about vaccines in general. Moreover, people who declare that they have too little (not enough) information about vaccines tend to present a negative attitude toward vaccination.  It is also said in this study that, the threat of disease during an outbreak may change attitudes towards vaccination. People who have not been vaccinated previously (For various reasons) may decide to get vaccines. (Ewa, et al, 2021).

African countries are at a higher risk of disease spread due to limited health infrastructure and training, their inability to promptly obtain the vaccine further increased the risk of disease spread. Not only have many developed countries ordered most of the vaccine supplies, but vaccine related cost and transfer issues may also further delay vaccination procedures for African people as far as late 2021 to early 2022. Waning public confidence in vaccine due to rumors and conspiracy theories is a major challenge for public health experts and policy makers Worldwide. Hesitation, spreading rumors and fake news can affect public mentality and vaccine decision. A known example is the 2003-2004 Nigerian boycott of the polio vaccine that resulted in a surge of the disease. Therefore, social endorsement and effort against hesitation regarding the COVID-19 vaccination are essential, especially in limited resources settings. (Elhadi, et al, 2021).


1.2.    AIM OF THE STUDY

To assess the public knowledge, attitudes and perceptions towards acceptance of COVID-19 vaccination in three selected communities (Namely: Ilekun community, Oda community, Esure community) in Akure south Local Government.


1.3. OBJECTIVES OF THE STUDY

1.    To determining the extent of knowledge of the public on COVID-19 and it's vaccination.

2.    To identify the beliefs and barriers associated with COVID-19 vaccination and their attitudes towards it.

3.     Determine the aftermath effect of COVID-19 vaccination on its acceptance among the people.


1.4. STATEMENT OF THE PROBLEM

  The unprecedented global health crisis we are facing (COVID-19) has caught much of the world off-guard and is affecting all parts of the society and changing lives and livelihoods, due to the spread of coronavirus that exist directly and indirectly, in an attempt to reduce the spread and eradicate this deadly disease in Akure South Local Government and the World at large a massive response need to be mounted by the Government, World Health Organization (WHO), and other Organizations involved in the care to enlighten the health workers and the general populace at large on the prevalence of COVID-19, the preventive measures and the acceptance of vaccines provided against COVID-19.


1.5. SIGNIFICANCE OF THE STUDY

This research work is relevant in several ways to communities, personnel, individual and government. The work will expose misinformation and vaccine hesitancy and improve the community knowledge and position their attitudes towards COVID-19 vaccine among the people of Akure; Also it will be a proper measure for preventing the deadly disease with the use of personal protective equipment.


1.6. ASSUMPTIONS

1.    It is commonly assumed that the vaccine is not safe and has a longterm effect on the health

2.    Generally, people assumed that they can get or be infected with COVID-19 from the vaccine.


1.7. DEFINITION OF TERMS

1.    COVID-19: Is an infectious disease caused by the SARS-COV-2 virus.

2.   SARS-COV-2: Severe Acute Respiratory Syndrome Coronavirus 2 caused COVID-19.

3. RHINORRHEA: A common viral infection of the nose and throat caused an excessive discharge of mucus from the nose.

4.    PRE-SYMPTOMATIC: Refer to infected people who have not yet developed symptoms but go on to develop symptoms late.

5.    ASYMPTOMATIC: Refer to people who are infected but never develop any symptoms.

6.  COMORBIDITY: Is the presence of one or more additional condition often co-occuring with a primary condition. Comorbidity describes the effect of all other conditions and individual patient might have other than primary condition.

7. FOMITES: Refer to objects or materials which are likely to carry infection, such as clothes, utensils, and furniture.

8.    CDC: Center of Disease Control and Prevention.

9.  CATASTROPHIC: Involving or causing sudden great damage or suffering.

10.PANDEMIC: Is an outbreak of disease that spread across countries or continents.

 

 

Click “DOWNLOAD NOW” below to get the complete Projects

FOR QUICK HELP CHAT WITH US NOW!

+(234) 0814 780 1594

Buyers has the right to create dispute within seven (7) days of purchase for 100% refund request when you experience issue with the file received. 

Dispute can only be created when you receive a corrupt file, a wrong file or irregularities in the table of contents and content of the file you received. 

ProjectShelve.com shall either provide the appropriate file within 48hrs or send refund excluding your bank transaction charges. Term and Conditions are applied.

Buyers are expected to confirm that the material you are paying for is available on our website ProjectShelve.com and you have selected the right material, you have also gone through the preliminary pages and it interests you before payment. DO NOT MAKE BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.

In case of payment for a material not available on ProjectShelve.com, the management of ProjectShelve.com has the right to keep your money until you send a topic that is available on our website within 48 hours.

You cannot change topic after receiving material of the topic you ordered and paid for.

Ratings & Reviews

0.0

No Review Found.


To Review


To Comment